Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 195 participants.

Also called NCT02787161

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 195 participants (enrolled count) (from the registry)
Sponsor
Pontifícia Universidade Católica do Paraná (from the registry)
Registry
  • NCT NCT02787161
Other papers using this trial's data
  • High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial Journal of nephrology, 2022-06 DOI, PubMed 35239175
  • Impact of hemodialysis and post-dialysis period on granular activity levels BMC nephrology, 2020-05-25 DOI, PubMed 32450793, PMC7249440 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02787161. Randomized; no masking; primary purpose treatment. Start 2016-08 (actual); primary completion 2018-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes
Acronym
HDFIT
Intervention (Device)
Hemodiafiltration
Intervention (Device)
Hemodialysis
Lead sponsor
Pontifícia Universidade Católica do Paraná (class: other)
Collaborator
Fresenius AG (class: industry)

Record details

Record id
cardio:ct-nct02787161
Content hash
b982a48149ceebc705cca6f94bd2b42a70aa71ded0bd159d837424335676818c